Apotheek A. Janssens SRL
Apotheek A. Janssens reported total assets of 55,793 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Apotheek A. Janssens shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +31 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek A. Janssens's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 14 Aug 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
Apotheek A. Janssens's financial analysis
- Solvency73.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek A. Janssens
Apotheek A. Janssens's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0875.061.942
- VAT number
- BE0875061942
- Peppol
- Registered · 0208:0875061942 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jul 2005
- Registered office
- 3630 Maasmechelen
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek A. Janssens (SRL) has been based in Maasmechelen since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 5,383 € and equity of 40,868 €; its revenue is not published. Its solvency stands at 73.2%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek A. Janssens
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Pharmaes Retail sale of pharmaceutical products Anderlecht · balance sheet 57,673 €
- Sevens Elise Retail sale of pharmaceutical products Wetteren · balance sheet 53,817 €
- Sarah Spruyt Pharma & Care Retail sale of pharmaceutical products Mechelen · balance sheet 58,307 €
- Bephacon Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 52,631 €
- Charlotte Slabbinck Retail sale of pharmaceutical products Oudenburg · balance sheet 72,938 €
- Astrid Fivez Retail sale of pharmaceutical products Destelbergen · balance sheet 52,168 €
- P.H.A. Retail sale of pharmaceutical products Anderlecht · balance sheet 60,047 €
Frequently asked questions about Apotheek A. Janssens
What is the revenue of Apotheek A. Janssens?
Apotheek A. Janssens files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek A. Janssens?
In Belgium, the VAT number is the company number prefixed with BE: BE0875061942 for Apotheek A. Janssens, if the company is VAT-registered. Its company number (CBE) is 0875.061.942.
Where is the registered office of Apotheek A. Janssens?
According to the CBE register, the registered office of Apotheek A. Janssens is in 3630 Maasmechelen.
What is the equity of Apotheek A. Janssens?
At the close of the 2025 financial year, the equity of Apotheek A. Janssens amounts to 40,868 €, a solvency of 73.2% of total assets.
Who manages Apotheek A. Janssens?
The register lists 1 active mandates at Apotheek A. Janssens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek A. Janssens
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →